Related Experiment Video
Updated: Jul 16, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Optimal management strategies for chronic iron overload
1Southern Iron Disorders Center, Birmingham, Alabama 35209, USA. ironmd@dnamail.com
Drugs
|March 28, 2007
Summary
Iron overload requires treatment due to organ damage. Therapies like phlebotomy and chelation improve quality of life and survival by removing excess iron.
Area of Science:
- Hematology
- Internal Medicine
- Clinical Therapeutics
Background:
- Iron overload disorders are prevalent globally, causing significant organ damage, particularly in the heart, liver, and endocrine system.
- Limited physiological mechanisms for iron excretion necessitate medical intervention for affected individuals.
- Effective treatment is crucial for managing co-existing medical conditions and preventing severe health consequences.
Purpose of the Study:
- To characterize major iron overload disorders.
- To tabulate methods for evaluating and treating iron overload.
- To describe available treatment options and propose future research directions.
Main Methods:
- Review of existing literature on iron overload disorders and their management.
- Tabulation of diagnostic and therapeutic approaches.
- Discussion of treatment benefits and limitations.
Main Results:
- Iron overload leads to dysfunction in vital organs including the heart, liver, pancreas, and joints.
- Treatment options include phlebotomy, erythrocytapheresis, and chelation therapy.
- Therapeutic interventions aim to prevent mortality from cardiac siderosis and hepatic cirrhosis, and endocrine damage.
Conclusions:
- Safe and effective treatments for iron overload are essential for improving patient outcomes.
- Preventing iron-induced organ injury enhances quality of life and survival.
- Further research is needed to advance the understanding and treatment of iron overload disorders.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...